Immunocore Holdings plc (IMCR) Financials
IMCR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 597.0 million | 228.2 million |
2023-09-30 | 464.1 million | 172.6 million |
2023-06-30 | 440.4 million | 163.1 million |
2023-03-31 | 430.5 million | 156.4 million |
IMCR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -9.1 million | 12.1 million |
2023-09-30 | 3.4 million | 6.7 million |
2023-06-30 | -3.2 million | 7.0 million |
2023-03-31 | 6.3 million | 6.7 million |
IMCR Net Income
No data available :(
IMCR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 442.6 million | - | 36.0 million |
2023-09-30 | 364.0 million | - | 30.9 million |
2023-06-30 | 342.3 million | - | 29.1 million |
2023-03-31 | 337.5 million | - | 29.5 million |
IMCR Shares Outstanding
IMCR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 471000 | 74.7 million | 47.0 million | 17.2 million |
2023-09-30 | 1.7 million | 31.7 million | 11.0 million | - |
2023-06-30 | 768000 | 28.8 million | 36.0 million | - |
2023-03-31 | 2.5 million | 28.4 million | 33.3 million | - |
IMCR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 105.6 million | -247000 |
2023-09-30 | 51.5 million | 220000 |
2023-06-30 | 47.8 million | 886000 |
2023-03-31 | 44.5 million | 178000 |
IMCR
Price: $58.46
52 week price:
Earnings Per Share: -1.43 USD
P/E Ratio: -52.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 522338
Market Capitalization: 3.2 billion